84 related articles for article (PubMed ID: 22301191)
1. Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU.
Kim NH; Kim SN; Oh JS; Lee S; Kim YK
Biochem Biophys Res Commun; 2012 Feb; 418(4):616-21. PubMed ID: 22301191
[TBL] [Abstract][Full Text] [Related]
2. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
Kim SN; Kim NH; Park YS; Kim H; Lee S; Wang Q; Kim YK
Biochem Pharmacol; 2009 Jun; 77(12):1773-9. PubMed ID: 19428332
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
Won HJ; Ha TK; Kwon SJ; Cho HY; Hur SJ; Baik HH; Suh SI; Ha E; Kim YH
Anticancer Drugs; 2010 Mar; 21(3):270-6. PubMed ID: 20023572
[TBL] [Abstract][Full Text] [Related]
4. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
6. RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase.
Lee KH; Hur HS; Im SA; Lee J; Kim HP; Yoon YK; Han SW; Song SH; Oh DY; Kim TY; Bang YJ
Cancer Lett; 2010 Dec; 299(1):22-8. PubMed ID: 20727673
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
Seo JS; Kim TG; Hong YS; Chen JY; Lee SK
Arch Pharm Res; 2011 Apr; 34(4):635-43. PubMed ID: 21544729
[TBL] [Abstract][Full Text] [Related]
8. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.
Xian XS; Park H; Choi MG; Park JM
Anticancer Res; 2013 Jun; 33(6):2541-7. PubMed ID: 23749906
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells.
Zhou XX; Ji F; Zhao JL; Cheng LF; Xu CF
J Gastroenterol Hepatol; 2010 Jul; 25(7):1266-75. PubMed ID: 20594254
[TBL] [Abstract][Full Text] [Related]
13. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of interferon regulatory factor 1 enhances chemosensitivity to 5-fluorouracil in gastric cancer cells.
Gao J; Tian Y; Zhang J
J Cancer Res Ther; 2012; 8(1):57-61. PubMed ID: 22531515
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
16. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.
Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
Chem Biol Interact; 2007 Jun; 168(2):143-58. PubMed ID: 17512508
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
Eur J Pharmacol; 2007 Aug; 569(1-2):16-28. PubMed ID: 17585902
[TBL] [Abstract][Full Text] [Related]
19. [Bcl-XL antisense oligodeoxynucleotide sensitizes human esophageal cancer cell line to 5-fluorouracil].
Zhang L; Wen HT; Wang LX; Zhang L; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):173-7. PubMed ID: 16875599
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
